Connect with MMS

MMS is the leading data-focused CRO dedicated to supporting your needs. To request more information or to speak with a representative from MMS, please use this form and one of our colleagues will contact you shortly.

MMS locations map
North America
MMS Holdings Inc.
6880 Commerce Blvd.
Canton, MI 48187, USA
info@mmsholdings.com
Asia
MMSH Clinical Research Pvt. Ltd.
2/1, Dr. Rajkumar Road,
Rajajinagar
Bangalore 560010, India
Asia@mmsholdings.com
Europe
MMS Holdings Europe Ltd. Spaces Covent Garden
60 St Martins Lane
London, WC2N 4JS
United Kingdom
Europe@mmsholdings.com
South Africa
Postnet Preller Suite 3
Private Bag X01
Heuwelsig 9332, Bloemfontein
South Africa
 SA@mmsholdings.com
Asia
Sonthalia (Dwaraka)
Mindspace, Suite 401,
Madhapur Hyderabad 500081
India
Asia@mmsholdings.com
Europe
Regus House, Harcourt Centre
Harcourt Road, Dublin,
D02 HW77
Republic of Ireland
Europe@mmsholdings.com

Suggested For You

news

November 19th, 2024

MMS Recognized as a Top Workplace by Detroit Free Press and USA Today Network for the Fourth Consecutive Year

perspectives

November 12th, 2024

REMS Logic Modeling: Applying FDA Guidance from November 2024 CDER Webinar

news

November 8th, 2024

MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

perspectives

November 6th, 2024

How to Successfully Manage Rescue Studies and Turn Around Clinical Trials Facing Failure

perspectives

October 29th, 2024

Why Outsourcing QC of Regulatory and Medical Writing Documents is a Competitive Advantage for Large Pharma Companies

perspectives

October 22nd, 2024

Choosing the Right Clinical Trial Design: A Crucial Step in Protocol Development

perspectives

October 15th, 2024

Putting the Action in Diversity Action Plans and the Real-Time Data Visualization Technology Needed to Ensure It Happens

news

October 15th, 2024

MMS Recognized with EcoVadis Bronze Medal for Leadership in ESG Sustainability Efforts as a Leading Clinical Research Organization (CRO)

perspectives

October 8th, 2024

Diversity Action Plan Guidance Part I: Implications for Sponsors

webinar

October 22nd, 2024

Optimal Strategies to Protect Commercially Confidential Information (CCI) in Clinical Documents and Report Trial Results Under Revised EU-CTIS Transparency Rules

perspectives

September 30th, 2024

Meet the Leaders Driving MMS’s European Growth

perspectives

September 30th, 2024

The Future of Data Management and Biostatistics: Trends and Technologies Shaping the Industry